Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$19.86 - $29.09 $4.66 Million - $6.83 Million
-234,817 Reduced 52.49%
212,559 $4.84 Million
Q1 2024

May 15, 2024

SELL
$28.21 - $37.78 $10.5 Million - $14 Million
-370,507 Reduced 45.3%
447,376 $13.6 Million
Q4 2023

Feb 14, 2024

BUY
$32.99 - $43.25 $2.32 Million - $3.04 Million
70,323 Added 9.41%
817,883 $29.2 Million
Q3 2023

Nov 14, 2023

SELL
$41.12 - $57.73 $43,299 - $60,789
-1,053 Reduced 0.14%
747,560 $32.7 Million
Q2 2023

Aug 14, 2023

BUY
$40.44 - $49.6 $4.1 Million - $5.03 Million
101,391 Added 15.67%
748,613 $37 Million
Q1 2023

May 15, 2023

BUY
$35.87 - $47.22 $111,663 - $146,995
3,113 Added 0.48%
647,222 $26.8 Million
Q4 2022

Feb 14, 2023

BUY
$33.48 - $47.45 $55,643 - $78,861
1,662 Added 0.26%
644,109 $28.6 Million
Q3 2022

Nov 14, 2022

BUY
$38.25 - $52.62 $21,075 - $28,993
551 Added 0.09%
642,447 $25.1 Million
Q2 2022

Aug 11, 2022

BUY
$35.1 - $66.01 $1.52 Million - $2.86 Million
43,291 Added 7.23%
641,896 $26.2 Million
Q1 2022

May 13, 2022

BUY
$57.43 - $71.39 $5.75 Million - $7.14 Million
100,049 Added 20.07%
598,605 $39.3 Million
Q4 2021

Feb 10, 2022

BUY
$63.4 - $87.14 $5.11 Million - $7.02 Million
80,540 Added 19.27%
498,556 $34.7 Million
Q3 2021

Nov 12, 2021

BUY
$69.28 - $84.46 $3.02 Million - $3.68 Million
43,598 Added 11.64%
418,016 $29.1 Million
Q2 2021

Aug 12, 2021

SELL
$64.13 - $80.18 $7.91 Million - $9.89 Million
-123,294 Reduced 24.77%
374,418 $29.7 Million
Q1 2021

May 12, 2021

SELL
$53.79 - $66.98 $3.16 Million - $3.93 Million
-58,662 Reduced 10.54%
497,712 $32.6 Million
Q4 2020

Feb 16, 2021

BUY
$34.56 - $57.55 $19.2 Million - $32 Million
556,374 New
556,374 $31 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.63B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.